These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2881900)

  • 41. β-Adrenergic receptor blockade does not modify non-thermal sweating during static exercise and following muscle ischemia in habitually trained individuals.
    Amano T; Igarashi A; Fujii N; Hiramatsu D; Inoue Y; Kondo N
    Eur J Appl Physiol; 2018 Dec; 118(12):2669-2677. PubMed ID: 30238251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of -adrenoceptor blockade on human sweating.
    Allen JA; Jenkinson DJ; Roddie IC
    Br J Pharmacol; 1973 Mar; 47(3):487-97. PubMed ID: 4147190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.
    Levine MA; Ogilvie RI; Leenen FH
    Clin Pharmacol Ther; 1988 Jan; 43(1):39-48. PubMed ID: 2826066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exercise training during long-term beta-blockade treatment in healthy subjects.
    Savin WM; Gordon EP; Kaplan SM; Hewitt BF; Harrison DC; Haskell WL
    Am J Cardiol; 1985 Apr; 55(10):101D-109D. PubMed ID: 3993543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of a week's beta-adrenoceptor antagonism on daytime heart-rates, subjective responses to exercise, and physical activity in normal subjects.
    Patrick JM; Wharrad HJ; Wilson CG; Birmingham AT
    Br J Clin Pharmacol; 1985 Feb; 19(2):177-85. PubMed ID: 2859043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide.
    Twum-Barima Y; Ahmad D; Hamilton JT; Carruthers SG
    Clin Pharmacol Ther; 1982 Sep; 32(3):289-94. PubMed ID: 6125288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men.
    Wilcox RG; Bennett T; Macdonald IA; Herbert M; Skene AM
    Br J Clin Pharmacol; 1984 Mar; 17(3):273-81. PubMed ID: 6712861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Localized β-adrenergic receptor blockade does not affect sweating during exercise.
    Buono MJ; Tabor B; White A
    Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1148-51. PubMed ID: 21325648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of beta-adrenoceptor blockade on post-exercise oxygen consumption.
    Børsheim E; Bahr R; Hansson P; Gullestad L; Hallén J; Sejersted OM
    Metabolism; 1994 May; 43(5):565-71. PubMed ID: 7909912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of beta-adrenergic blockade on the control of sweating in humans.
    Mack GW; Shannon LM; Nadel ER
    J Appl Physiol (1985); 1986 Nov; 61(5):1701-5. PubMed ID: 3023274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of beta-adrenoceptor blockade on exercise performance and respiratory response in healthy, physically untrained humans.
    Violante B; Buccheri G; Brusasco V
    Br J Clin Pharmacol; 1984 Dec; 18(6):811-5. PubMed ID: 6152174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.
    Elliott HL; Meredith PA; McNally C; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):379-85. PubMed ID: 1777376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade.
    Fletcher GF; Sweeney ME; Fletcher BJ
    Am Heart J; 1991 Jan; 121(1 Pt 1):105-10. PubMed ID: 1670740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.
    Currie D; Lewis RV; McDevitt DG; Nicholson AN; Wright NA
    Br J Clin Pharmacol; 1988 Aug; 26(2):121-8. PubMed ID: 2905148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of calcium and beta-adrenoceptor antagonists on beta-adrenoceptor density and Gs alpha expression in human atria.
    Jones CR; Fandeleur P; Harris B; Bühler FR
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):171S-173S. PubMed ID: 1980078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro effects of calcium channel blockers and beta-adrenergic blocking agents on microsomal lipid perocidation and cytochrome p-450 content.
    Alov P; Koleva M; Kastelova A
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):277-81. PubMed ID: 10445382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of alpha 1-adrenoceptor and Ca2+ channel inhibition on norepinephrine-induced thermoregulatory behavior in the cold.
    Carlisle HJ; Stock MJ
    Pharmacol Biochem Behav; 1997; 57(1-2):185-9. PubMed ID: 9164571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of a new calcium-antagonist PN 200-110 and nifedipine to affect exercise stimulated GH-secretion in healthy volunteers.
    Sieber C; del Pozo E
    Horm Metab Res; 1987 Jun; 19(6):281-2. PubMed ID: 2957296
    [No Abstract]   [Full Text] [Related]  

  • 59. The pharmacological protection of the ischaemic heart: the use of calcium and beta-adrenoceptor antagonists.
    Nayler WG
    Eur Heart J; 1980 Dec; 1(Suppl B):5-13. PubMed ID: 6128229
    [No Abstract]   [Full Text] [Related]  

  • 60. The selectivity of the beta-adrenoceptor for ventilation in man.
    Butland RJ; Pang JA; Geddes DM
    Br J Clin Pharmacol; 1982 Nov; 14(5):707-11. PubMed ID: 6128020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.